Arrowhead Pharmaceuticals, Inc. - Common Stock (ARWR) stock analysis

ARWR · Arrowhead Pharmaceuticals, Inc. - Common Stock

Latest recorded price: USD 44.21

Sector and industry: Healthcare · Biotechnology

A reliable intrinsic value could not be calculated for ARWR; the assessment relies on sector multiple comparisons. Fiscal 2025 figures: revenue growth 50.5%, free cash flow margin 18.9%. The model flags 1 risk signal for this company.

Similar companies in Healthcare